Filing Details
- Accession Number:
- 0001415889-24-007315
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-08 15:40:49
- Reporting Period:
- 2024-03-07
- Accepted Time:
- 2024-03-08 15:40:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
856982 | Merit Medical Systems Inc | MMSI | Surgical & Medical Instruments & Apparatus (3841) | 870447695 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1643713 | Joseph Wright | 1600 West Merit Parkway South Jordan UT 84095 | Chief Commercial Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, No Par Value | Acquisiton | 2024-03-07 | 25,000 | $28.20 | 67,223 | No | 4 | M | Direct | |
Common Stock, No Par Value | Disposition | 2024-03-07 | 25,000 | $75.68 | 42,223 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified stock options (right to buy) | Disposition | 2024-03-07 | 25,000 | $0.00 | 25,000 | $28.20 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2018-04-14 | 2024-04-14 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified stock options (right to buy) | $44.80 | 2019-03-02 | 2025-03-02 | 25,000 | 25,000 | Direct |
Common Stock | Non-qualified stock options (right to buy) | $55.73 | 2020-03-01 | 2026-03-01 | 30,000 | 30,000 | Direct |
Common Stock | Non-qualified stock options (right to buy) | $37.71 | 2021-02-26 | 2027-02-26 | 16,722 | 16,722 | Direct |
Common Stock | Non-qualified stock options (right to buy) | $56.25 | 2022-03-19 | 2028-03-19 | 9,681 | 9,681 | Direct |
Common Stock | Non-qualified stock options (right to buy) | $65.03 | 2023-02-28 | 2029-02-28 | 8,094 | 8,094 | Direct |
Common Stock | Non-qualified stock options (right to buy) | $70.58 | 2024-02-28 | 2030-02-28 | 13,576 | 13,576 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2025-03-02 | 25,000 | 25,000 | Direct |
2026-03-01 | 30,000 | 30,000 | Direct |
2027-02-26 | 16,722 | 16,722 | Direct |
2028-03-19 | 9,681 | 9,681 | Direct |
2029-02-28 | 8,094 | 8,094 | Direct |
2030-02-28 | 13,576 | 13,576 | Direct |
Footnotes
- The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.234 to $76.220, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018.
- Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019.
- Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020.
- Becomes exercisable in equal annual installments of 25% commencing on 02/26/2021.
- Becomes exercisable in equal annual installments of 25% commencing on 03/19/2022.
- Becomes exercisable in equal annual installments of 25% commencing on 02/28/2023.
- Becomes exercisable in equal annual installments of 25% commencing on 02/28/2024.